Company Filing History:
Years Active: 2009
Title: The Innovative Contributions of Richard P. Darveau
Introduction
Richard P. Darveau is a notable inventor based in Redmond, WA (US). He has made significant contributions to the field of immunology through his innovative research and patent work. His expertise lies in developing immune system modulators that can redirect the host's immune response against specific antigens.
Latest Patents
Richard P. Darveau holds a patent for a preparation containing lipopolysaccharide (LPS) with a molecular negative mass ion of 1435 or 1449. This preparation is utilized as an immune system modulator, which can stimulate an immune response against various diseases, including tumors, infectious diseases, and autoimmune conditions. The 1435/1449 LPS preparation can be isolated or prepared as a derivative or mimetic, making it a versatile tool in vaccine adjuvants and treatments for inflammatory conditions.
Career Highlights
Darveau is affiliated with the University of Washington, where he conducts his research and development work. His career has been marked by a commitment to advancing the understanding of immune responses and developing innovative solutions to combat diseases.
Collaborations
Throughout his career, Richard has collaborated with esteemed colleagues, including Robert Reife and Keith L. Knutson. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Richard P. Darveau's work exemplifies the impact of innovative research in the field of immunology. His contributions through patents and collaborations continue to influence the development of new therapeutic strategies.